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Leber hereditary optic neuropathy (LHON) is a mitochondrial
genetic disorder characterized by a progressive bilateral optical
atrophy. The disease is caused by mutations resulting in single
amino acid exchange in one of the mitochondrially-encoded ND
subunits of NADH:ubiquinone oxidoreductase, the ﬁrst complex of
the electron transport chain [1]. As reported in the literature, all
LHON mutations lead to an impairment of mitochondrial function.
Extensive biochemical studies on patient's tissues and cell models
of the disease showed decreased respiration, overproduction of
reactive oxygen species (ROS) and increased propensity to
apoptotic cell death [2, 3, 4]. Mitochondrial respiration defects
and increased ROS production were conﬁrmed more recently in a
mouse model of LHON [5]. We examined the role of nitric oxide, a
master regulator of mitochondrial function, and hypoxia on cell
viability and bioenergetics of lymphoblastoid cells from patients
carrying the most frequent mutation 11778/ND4. Results indicate
that, compared to controls, cells carrying the pathogenic mutation
are more susceptible to nitrosative stress, while looking better
adapted to hypoxia.
References
[1] A.A. Sadun, C. La Morgia, V. Carelli, Leber's Hereditary Optic
Neuropathy, Curr. Treat. Options Neurol. 13 (2011) 109–117.
[2] E. Kirches, LHON: Mitochondrial Mutations and More, Curr.
Genomics 12 (2011) 44–54.
[3] M.D. Brown, I.A. Trounce, A.S. Jun, J.C. Allen, D.C.Wallace, Functional
analysis of lymphoblast and cybrid mitochondria containing the
3460, 11778, or 14484 Leber's hereditary opticneuropathy mito-
chondrial DNA mutation, J.Biol.Chem. 275 (2000) 39831–39836.
[4] V. Carelli, M .Rugolo, G. Sgarbi, A. Ghelli, C. Zanna, A. Baracca, G.
Lenaz, E. Napoli, A.Martinuzzi, G. Solaini, Bioenergetics shapes cellular
death pathways in Leber's hereditary optic neuropathy: a model of
mitochondrial neurodegeneration, BBA 1658 (2004) 172–179.
[5] C.S. Lin, M.S. Sharpley, W. Fan, K.G. Waymire, A.A. Sadun,
V. Carelli, F.N. Ross-Cisneros, P. Baciu, E. Sung, M.J. McManus,
B.X. Pan, D.W. Gil, G.R. Macgregor, D.C. Wallace, Mouse mtDNA
mutant model of Leber hereditary optic neuropathy, PNAS
(2012) 20065–20070.
doi:10.1016/j.bbabio.2014.05.009
S7.P3
The mitochondrial gas pedal: Cytosolic Ca2+ regulates the
mitochondrial energization with pyruvate either via the malate–
aspartate-shuttle and (or) glycerol-3-phosphate shuttle — New
evidences from experiments with synaptosomes
Frank Gellericha, Zemﬁra Gizatullinab, Timur Gainutdinowc,
Joosep Seppetd, Mart Roosimaad, Rodrigo Herrera-Molinab,
Katharina Muthe, Rebecca Königb, Maria Riek-Burchardb,
Grazina Debska-Vielhaberc, Stefan Vielhaberc
aNeurologische Universitätsklinik Magdeburg, Germany
bDepartment for Behavioral Neurology, Leibniz Institute for Neurobiology,
Germany
cDepartment of Neurology, Otto von Guericke University of Magdeburg,
Germany
dDepartment of Pathophysiology, University of Tartu, Estonia
eDepartment of Neurology, Otto von Guericke University of Magdeburg,
Germany
E-mail address: frank.gellerich@med.ovgu.de
The paradigmatic view on the Ca2+-regulation of OXPHOS is that
Ca2+cyt after its uptake by the mitochondrial Ca2+ uniporter activates
matrix dehydrogenases. However, we have shown that Ca2+cyt
activates the glutamate/malate as well as the glycero-3-phosphate
(G3P)-dependent OXPHOS of isolated brain mitochondria (BM) by
more than 300%. In contrast the OXPHOS capacity with pyruvate/
malate increases under the same conditions by 15% only [1]. The
strong activation of state 3Glu/Mal and state 3G3P by Ca2+cyt is realized
via aralar, the glutamate–aspartate carrier and the mtG3PDH. Both
enzymes have regulatory Ca2+ binding sites at the mitochondrial
surface making their activity Ca2+cyt sensitive. Both enzymes are
central components of the malate aspartate shuttle (MAS) and G3P
shuttle (G3PS). With reconstituted systems we now demonstrate at
BM that Ca2+cyt also controls the activity of G3PS similar as shown
before for the MAS [1]. Both shuttles are metabolically connected
with the oxidizing reactions of pyruvate formation via their common
substrate couple NADH/NAD+. We called this mechanism “mito-
chondrial gas pedal” [2]. We now further demonstrate the existence
of the gas pedal in intact synaptosomes: The Ca2+-chelating agent
BAPTA-AM decreases (i) the Ca2+cyt from 76 ± 11 nM to 15 ± 11 nM,
(ii) the glucose/lactate dependent respiration by 47%, and (iii) the
cytosolic pyruvate concentration by 40%. The inhibition of respiration
can be reversed by pyruvate additions although the Ca2+cyt remains
low, indicating that Ca2+cyt controls the mitochondrial substrate
supply via the rate of pyruvate formation causing variations of
cytosolic pyruvate concentrations.
Comparing BM isolated from different brain regions with
varying relative neuron content we found that the MAS-driven
gas pedal is a typical property of neurons and occurs not in
astrocytes. In contrast the G3PS-driven gas pedal is a typical
property of astrocytes but occurs also in neurons. This difference
is a consequence of varying enzyme pattern in neurons and
astrocytes as well as in their mitochondria. Astrocyte mitochon-
dria take up glutamate via the glutamate carrier but neuronal
mitochondria use aralar for that. Based on these ﬁndings we are
able to assess typical neuronal and astrocytic properties in BM
isolated from brain regions of neurodegenerative model animals.
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